Patents by Inventor Steven L. Hauser

Steven L. Hauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEISSERIA MENINGITIDIS VACCINE
    Publication number: 20230310567
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for vaccinating a subject against Neisseria meningitidis.
    Type: Application
    Filed: June 7, 2023
    Publication date: October 5, 2023
    Applicant: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, JR., Steven L. Hauser
  • Neisseria meningitidis vaccine
    Patent number: 11707514
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for vaccinating a subject against Neisseria meningitidis.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: July 25, 2023
    Assignee: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, Jr., Steven L. Hauser
  • COMBINED IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE AND HUMAN PAPILLOMAVIRUS
    Publication number: 20220031829
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for immunization against Neisseria meningitidis serogroups A, C, Y, and W-135 and human papilloma virus.
    Type: Application
    Filed: September 27, 2019
    Publication date: February 3, 2022
    Applicant: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, Jr., Steven L. Hauser, Emilia Ivanova Jordanov, Mandeep Singh Dhingra, David Neveu
  • NEISSERIA MENINGITIDIS VACCINE
    Publication number: 20210401964
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for vaccinating a subject against Neisseria meningitidis.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Applicant: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, JR., Steven L. Hauser
  • vaccine
    Patent number: 11147866
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for vaccinating a subject against Neisseria meningitidis.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: October 19, 2021
    Assignee: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, Jr., Steven L. Hauser
  • NEISSERIA MENINGITIDIS VACCINE
    Publication number: 20190175718
    Abstract: Provided herein are compounds, compositions, formulations, kits, uses, and methods for vaccinating a subject against Neisseria meningitidis.
    Type: Application
    Filed: February 21, 2019
    Publication date: June 13, 2019
    Applicant: Sanofi Pasteur Inc.
    Inventors: Richard David Kensinger, JR., Steven L. Hauser
  • Alkylated influenza vaccines
    Patent number: 10124056
    Abstract: The present invention provides, among other things, improved influenza vaccines based on hemagglutinins containing one or more alkylated cysteine residues. In particular, the present invention provides influenza vaccines containing hemagglutinins treated with an alkylating agent and methods of making the same. Inventive influenza vaccines provided by the present invention have a remarkable ability to retain potency as determined by Single Radial Immunodiffusion (SRID) assay upon storage.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: November 13, 2018
    Assignee: Sanofi Pasteur Inc.
    Inventors: Brooke S. Milner, Jonathan Haines, Steven L. Hauser, Janet Beebe Poli
  • ALKYLATED INFLUENZA VACCINES
    Publication number: 20160045590
    Abstract: The present invention provides, among other things, improved influenza vaccines based on hemagglutinins containing one or more alkylated cysteine residues. In particular, the present invention provides influenza vaccines containing hemagglutinins treated with an alkylating agent and methods of making the same. Inventive influenza vaccines provided by the present invention have a remarkable ability to retain potency as determined by Single Radial Immunodiffusion (SRID) assay upon storage.
    Type: Application
    Filed: August 18, 2015
    Publication date: February 18, 2016
    Inventors: Brooke S. Milner, Jonathan Haines, Steven L. Hauser, Janet Beebe Poli